جست‌وجوی استاد و پژوهشگر

Sven Pankeمشاهده پروفایل

استاد

• Bioprocess Engineering
• Synthetic Biology
• Fermentation Technology
• +۳ مورد دیگر

Prof. Dr. Sven Panke is a Full Professor and Head of the Department of Biosystems Science and Engineering at ETH Zürich. His research focuses on bioprocess engineering, synthetic biology, and enzymatic process development. Key areas include miniaturized bioreactor systems, microbial engineering for novel metabolite production, and high-throughput screening methodologies. Education: Studied Biotechnology at TU Braunschweig, with postgraduate research at the German National Research Center for Biotechnology and ETH Zurich. Transitioned from industry (DSM) to academia in 2001 as an Assistant Professor, progressing to Associate Professor (2007-2009) before leading the BSS department. Research interests emphasize directed evolution of enzymes, metabolic pathway engineering, and systems biology approaches to optimize microbial production systems. Current projects include bio-indigo synthesis, antimicrobial peptide discovery, and synthetic biology tools for cellular engineering. Labs/Teams: Leads the Bioprocess Engineering Lab at ETH Zurich, collaborating on projects like the E. coli import system design and γ-glutamyltransferase engineering. Active in developing microfluidics platforms for parallel reaction analysis. Grants/Advising: Funded by initiatives in sustainable biomanufacturing and synthetic biology. Supervises graduate students in bioprocess design and microbial systems engineering.

Jouko Peltonenمشاهده پروفایل

استاد

• Materials Science
• Physical Chemistry
• Sustainable Technology
• +۳ مورد دیگر

Jouko Peltonen is a Professor in Chemistry at Åbo Akademi University's Faculty of Natural Sciences and Engineering. He leads the Laboratory of Molecular Science and Technology, focusing on sustainable material development and biomedical applications. His work aligns with UN Sustainable Development Goals through green chemistry innovations. Ph.D. in Chemistry (Åbo Akademi, 1994) Licentiate in Chemistry (Åbo Akademi, 1992) Master's in Chemistry (University of Helsinki, 1988) Peltonen's research spans materials science , polymer chemistry , and sustainable technology , with emphasis on nanocellulose composites , antibacterial materials , and bio-based packaging . Recent projects explore biofilm modeling and lignin valorization. His publications (216 total) demonstrate interdisciplinary impact across biomedical engineering , environmental science , and chemical manufacturing . Key collaborations include NordForsk-funded initiatives and EU projects like PACKER 2020. Research grants include: Printed Intelligence Infrastructure (Academy of Finland, 2024-2028) Nordic POP (NordForsk, 2018-2025) ABC-Health (Jane och Aatos Erkkos Foundation, 2021-2024)

Sebastian Hillerمشاهده پروفایل

استاد

• Structural Biology
• NMR Spectroscopy
• Protein Folding
• +۴ مورد دیگر

Professor Sebastian Hiller is a Full Professor at the Biozentrum of the University of Basel, Switzerland, where he leads a research group focused on structural biology and biophysics. His laboratory specializes in using nuclear magnetic resonance (NMR) spectroscopy to elucidate the structures and functions of proteins and their interactions at the atomic level. His research spans several key areas including molecular chaperones and protein folding mechanisms, outer membrane protein biogenesis in bacteria, and kinase signaling pathways. Notably, his group has made significant contributions to understanding how chaperones like trigger factor function, the mechanisms of outer membrane protein assembly through the Bam complex, and dynamic kinase interactions. Their work has direct implications for neurodegenerative diseases and antibiotic development. The Hiller lab's recent publications demonstrate a strong focus on NMR methodology development, protein folding dynamics, and structural mechanisms of antibiotic action. Their research on darobactin's mechanism of action against Gram-negative bacteria represents a significant advance in antibiotic discovery. The group frequently publishes in high-impact journals including Nature, Science, and Nature Communications. ICMRBS Founder's Medal (2018) EMBO Young Investigator (2014) ERC starting grant (2011) SNSF professorship (2010) SNSF scholarship for young researchers (2008) Professor Hiller supervises numerous PhD students and postdoctoral researchers, with many alumni having secured prestigious positions in academia and industry. His laboratory maintains strong collaborations across multiple institutions and has received significant funding through ERC grants and other competitive mechanisms. The Hiller group also operates advanced NMR facilities that serve the broader research community at the University of Basel.

Hyun-soon Chongمشاهده پروفایل

استاد

• Organic synthesis
• Medicinal chemistry
• Bioconjugate chemistry
• +۷ مورد دیگر

Hyun-soon Chong is a Professor of Chemistry at the Lewis College of Science and Letters , Illinois Institute of Technology. The Chong group focuses on interdisciplinary research spanning organic synthesis, medicinal chemistry, and nuclear medicine to develop targeted therapeutics for cancer and neurodegenerative diseases. Education : B.S. from Kyung Hee University, Ph.D. from the University of North Texas Research interests include: Organic synthesis using aziridinium ions Development of bifunctional chelators for radiotherapy/imaging Bioconjugate chemistry for antibody-drug conjugates Targeted cancer therapies and diagnostics Nuclear medicine applications with isotopes like Cu-64, Y-90, and Lu-177 Key publication trends show expertise in chelation chemistry, bioconjugation, and radiopharmaceutical development. The group has advanced aziridinium ion-based methodologies and created novel agents with preclinical efficacy. Labs/teams: The Chong group specializes in synthetic strategies for enantiomerically enriched molecules and biomedical chelators. Contact: chong@illinoistech.edu

• Virology
• Molecular Pathology
• Host-Pathogen Interactions
• +۵ مورد دیگر

Dr. Richard Y. Zhao is a tenured Professor in the Department of Pathology and Microbiology-Immunology at the University of Maryland School of Medicine. His research combines molecular biology, fission yeast genetics, mammalian biology, and virology to study virus-host interactions, particularly for HIV and Zika virus. He previously held academic positions at Northwestern University and Columbia University and has contributed to over 120 peer-reviewed articles. B.S., China Oceanography University (1981) M.S., Oregon State University (1995) Ph.D., Oregon State University (1991) Postdoctoral Training, Columbia University (1991-1992) Dr. Zhao's research focuses on: Virus-host interactions and pathogenicity High-throughput drug screening for antivirals Role of viral proteins in neuroinflammation and cancer Translational genomics in precision medicine His recent publications highlight SARS-CoV-2 ORF3a, Zika envelope proteins, and HIV protease inhibitors, emphasizing host-pathogen mechanisms across species. He has served on NIH panels and editorial boards for journals like Cell Research and Retrovirology . Scientific awards include: Fellow, American Academy of Microbiology (2019) Bernard L Mirkin Endowed Chair (2001-2004) Honorary Director, Shandong Gallo Institute (2009) Distinguished Service from SCBA (2015) Outstanding Service from CBA-USA (2016) Dr. Zhao also contributes to clinical diagnostics and personalized medicine through molecular testing and pharmacogenetics programs.

• Toxicology
• Environmental Toxicology
• Nanomaterial Toxicity
• +۳ مورد دیگر

Hans Bouwmeester is a Full Professor in Toxicology at Wageningen University & Research, specializing in chemical risk assessment, nanomaterial toxicity, and in vitro modeling. His work focuses on integrating artificial intelligence and physiologically based kinetic (PBK) models to predict toxic effects of contaminants like organophosphate pesticides, microplastics, and mycotoxins. He leads projects exploring the health impacts of foodborne contaminants in inflammatory bowel disease and developing animal-free testing methods. Key collaborations include EU initiatives like the ONTOX project and the GUTTEST program, which utilize advanced in vitro models such as gut-on-a-chip systems. Research interests span toxicokinetics, nanoplastics exposure, and the application of Bayesian networks for nanomaterial hazard ranking. His team addresses translational challenges in linking in vitro data to in vivo outcomes, with a focus on bile acid metabolism and cardiotoxicity prediction. Bouwmeester has supervised over 10 PhD candidates, including studies on microplastic hazard assessment, nanomaterial gastrointestinal fate, and AI-driven data extraction for risk assessment. Notable contributions include datasets on nanoplastics' protein corona effects and transcriptomic analyses of intestinal cell responses. His work is published in journals like Ecotoxicology and Environmental Safety , Toxicology , and Environmental Science & Technology , emphasizing open-access research and interdisciplinary approaches to chemical safety.

• Bioorganic Chemistry
• Chemical Biology
• Organic Chemistry
• +۵ مورد دیگر

Prof. Dr. Norbert Sewald, Chair of Organic and Bioorganic Chemistry at Bielefeld University, is a leading figure in Bioorganic Chemistry , Chemical Biology , and Enzymatic Halogenation . As head of the Organic and Bioorganic Chemistry Group at the Center for Biotechnology (CeBiTec), he drives research on natural products and drug conjugates. Full Professor, Bielefeld University (since 1999) Founding Coordinator, International Graduate School of Chemistry and Biochemistry (2001-2003) Chairman, Institute of Biochemistry and Bioengineering at CeBiTec (2006-2008) Dean, Department of Chemistry (2008-2011) Chairman, Max-Bergmann-Kreis e.V. (since 2010) Coordinator, Marie Skłodowska-Curie Training Networks (MAGICBULLET, 2015-2018; Magicbullet::reloaded, 2020-2023) His research focuses on halogenases for mild peptide bromination, cryptophycin-based tumor targeting , and bioactive natural products from African flora. Collaborative projects span antiplasmodial agents , antibacterial compounds , and neurodegenerative disease inhibitors . Recent work highlights include: Enzymatic halogenation cascades Click-to-release drug conjugates Fluorescent probes for amyloid detection Key affiliations: Faculty of Chemistry Center for Biotechnology (CeBiTec) European Peptide Society (Scientific Affairs Officer, 2016-) Leibniz Institute of Plant Biochemistry (Scientific Advisory Board, 2010-2017)

• Chronic Obstructive Pulmonary Disease (COPD)
• Respiratory Medicine
• Asthma
• +۴ مورد دیگر

Per Sigvald Bakke is a Professor at the University of Bergen's Faculty of Medicine, Department of Clinical Science, with extensive expertise in respiratory medicine. His research primarily focuses on Chronic Obstructive Pulmonary Disease (COPD), asthma, and related pulmonary conditions, with significant contributions to understanding disease mechanisms, clinical phenotyping, and epidemiology. Dr. Bakke's research interests span COPD phenotyping, asthma heterogeneity, genomics of respiratory diseases, pulmonary function testing, and clinical epidemiology. His work frequently involves large-scale cohort studies and international collaborations, particularly through the U-BIOPRED consortium. His research has significantly advanced understanding of COPD progression, exacerbation risk factors, and the relationship between respiratory diseases and systemic conditions like metabolic syndrome. His publication record demonstrates consistent contributions to respiratory medicine, with recent work focusing on multi-omics approaches to disease phenotyping, genetic determinants of lung function, and clinical management of COPD. His research often bridges basic science with clinical application, addressing critical questions in respiratory disease management and patient outcomes. Dr. Bakke has been instrumental in numerous international collaborative studies including the ECLIPSE cohort, U-BIOPRED, and various genome-wide association studies examining COPD and asthma. His work has contributed to clinical guidelines and improved understanding of respiratory disease mechanisms across diverse populations.

• Genetics
• Molecular Biology
• Gene Therapy
• +۴ مورد دیگر

Shushu Huang is an Associate Research Scientist in the Department of Genetics at Yale School of Medicine. They hold a PhD from Nanjing Medical University (2023) and an MD from the same institution (2013). Their research focuses on genetic and molecular mechanisms underlying metabolic disorders, muscular dystrophies, and cardiovascular diseases. Key areas include CRISPR-based therapeutic discovery, high-throughput functional genomics, and gene therapy safety. Huang has collaborated with researchers like Monkol Lek and Carlos Fernandez-Hernando on projects involving LXR signaling, DUX4 toxicity, and MC4R variant analysis. Publications span studies on vascular biology, gene therapy outcomes, and obesity genetics. Notable work includes investigating hypercholesterolemia’s role in vascular remodeling and analyzing MC4R variants in morbid obesity. Their lab is located in the Anlyan Center, New Haven.

• Biomaterials
• Regenerative Medicine
• Tissue Engineering
• +۴ مورد دیگر

Prof. Elisabeth Engel López leads the Biomaterials for Regenerative Therapies group at the Institute for Bioengineering of Catalonia (IBEC) and serves as a Professor at the Technical University of Catalonia. With over 80 publications in JCR journals, her work focuses on designing biomaterials and scaffolds for in vitro/in vivo regenerative medicine, emphasizing cellular response mechanisms and translational applications. Developing lactate-releasing systems for metabolic modulation Advancing 3D bioprinting for tissue-specific models Engineering angiogenic and osteogenic biomaterials Her research bridges fundamental studies with industrial partnerships, including pharmaceutical and biomedical device companies, and contributes to European collaborative projects. She received the Barcelona City Award for technological research and has delivered numerous invited lectures. Her group explores substrate stiffness, ion release, and microenvironmental cues to control cell behavior in cardiac, neural, and bone regeneration contexts.

• Systems Biology
• Cancer Research
• Drug Resistance
• +۷ مورد دیگر

Sampsa Hautaniemi is a Professor at the Department of Biochemistry and Developmental Biology within the Faculty of Medicine at the University of Helsinki. He serves as Principal Investigator of the Systems Biology of Drug Resistance in Cancer research group and holds docentship in the Faculty of Medicine. Professor Hautaniemi actively supervises doctoral students across multiple programs including the Doctoral Programme in Biomedicine, Doctoral Programme in Clinical Research, and Doctoral Programme in Integrative Life Science. His research focuses on systems biology approaches to understand drug resistance mechanisms in cancer, particularly ovarian cancer. His work integrates computational biology, genomics, epigenetics, and bioinformatics to develop precision medicine approaches for cancer treatment. His laboratory develops innovative computational methods and experimental models including patient-derived organoids to study tumor evolution, identify therapeutic targets, and predict treatment responses. Analysis of his recent publications reveals a strong emphasis on understanding tumor heterogeneity, clonal evolution during therapy, and the development of computational tools for cancer genomics. His work spans multiple disciplines including cancer biology, computational biology, immunology, and precision medicine, with a particular focus on high-grade serous ovarian cancer as a model system. Scientific Awards: The Anders Jahre Medical Prize to young medical scientists (2014) for outstanding research on systems biology and cancer The Finnish Medical Foundation 50-years jubileum award (2010) Professor Hautaniemi has supervised numerous doctoral students and early-career researchers, contributing significantly to cancer research education. His research is supported by multiple active projects including the DECIDER project (Clinical Decision via Integrating Multiple Data Levels to Overcome Chemotherapy Resistance in High-Grade Serous Ovarian Cancer) funded until 2026, as well as projects from the Academy of Finland, Cancer Foundation, and industry partners like Orion Corporation. His laboratory maintains a patient-derived organoid biobank for high-grade serous ovarian cancer and develops computational tools like Jellyfish for visualizing tumor evolution.

Sarah Jonesمشاهده پروفایل

دانشیار

• Thrombosis
• Haemostasis
• Platelet Biology
• +۳ مورد دیگر

Dr. Sarah Jones is an Associate Professor in Thrombosis and Haemostasis at Manchester Metropolitan University, serving as Deputy Director of Research for the Department of Life Sciences. She leads the Thrombosis Group and holds an honorary Reader position at the University of Manchester. Academic Affiliation: Manchester Metropolitan University Secondary Appointment: University of Manchester (Honorary Reader) Over 20 years, Dr. Jones has pioneered research on platelet signaling pathways and their role in thrombosis. Her current work focuses on platelet-endothelial crosstalk in disease states, with emphasis on in vitro thrombosis modeling to replace animal testing. This research, funded by BBSRC, NC3Rs, and BHF, addresses cardiovascular disease mechanisms and translational antithrombotic testing. Her scientific publications demonstrate expertise in platelet biology (Pim kinase signaling, SIRT1 regulation, proteoglycan interactions) and thrombosis modeling. Recent work includes placental perfusion studies for pregnancy-related cardiovascular complications. Grants & Projects: UKRI (NC3Rs) Partnership and Impact Award (2025-2026) UKRI BBSRC/NC3Rs grant for human haemostasis models (2023-2025) British Heart Foundation collaborations (2021-2025) Dr. Jones supervises PhD students (Mishaal Reyman, Poppy White, etc.) and teaches on Biomedical Science, Cellular Science, and Clinical Haematology programs. She has developed innovative endothelialised in-vitro thrombosis models that reduce animal usage in cardiovascular research.

David J. Mooreمشاهده پروفایل

استاد

• Neuropsychology
• HIV Neurobehavioral Research
• Neurocognitive Disorders
• +۵ مورد دیگر

David J. Moore, Ph.D., is a licensed clinical psychologist and Professor of Psychiatry at UC San Diego Health. He co-directs the SDSU/UCSD Joint Doctoral Program (JDP) in Clinical Psychology and leads research at the HIV Neurobehavioral Research Program (HNRP). His work focuses on neurocognitive impairments in individuals with HIV, comorbid mental illness, and substance use disorders, with a special emphasis on technological interventions for medication adherence. Doctorate: Ph.D. in Clinical Psychology (SDSU/UCSD JDP, neuropsychology specialization) Postdoctoral Fellowship: UCSD (serious mental illness) Clinical Internship: West Los Angeles VA Dr. Moore’s research addresses: Neurocognitive complications of HIV infection Intersection of HIV and aging Technological interventions for medication adherence Impact of comorbid psychiatric/substance use disorders on functioning His publications span topics including HIV neurocognitive profiles, syndemic factors in sexual risk behavior, and aging with HIV. Current studies integrate metabolomics, neuroimaging, and behavioral data through NIH-funded grants.

• Medical Microbiology
• Antimicrobial Resistance
• Biofilm Research
• +۳ مورد دیگر

Andrew Mcbain is a Professor of Microbiology at the University of Manchester, specializing in bacterial physiology, biofilm dynamics, and human microbiome research. He leads a research team supported by grants from research councils and industry, focusing on antimicrobial resistance, microbial community modeling, and host-microbe interactions. His work contributes to sustainable development goals related to health and environmental sustainability. Education: PhD in Medical Microbiology (University of Cambridge, 1997); BSc in Microbiology (University of Liverpool, 1993). Teaching: Courses include The Public (Year 2) , Medicines into Practice , and Drug Development Workshop . Research interests include in vitro modeling of microbial communities (e.g., biofilm reactors), probiotic applications, and clinical microbiota dynamics. He has supervised 39 PhD/MD students and collaborates with experts like Prof. Catherine O'Neill and Prof. Sheena Cruickshank. Key projects include Developing New Biocides (2019–2022) and Maternal Obesity and Extracellular Vesicles (2024–2027). His work has led to the creation of SkinBiotherapeutics PLC , advancing probiotic technologies for skin health. Grants: Includes funding from the Medical Research Council and industry partnerships. Lab Affiliations: Lydia Becker Institute and Christabel Pankhurst Institute at Manchester. Publications span over 213 articles, with recent focus on microbiome profiling, antimicrobial peptides, and light-based therapies. Awards include the W H Pierce Prize (2005) from the Society for Applied Microbiology.

• Veterinary Epidemiology
• Antimicrobial Resistance
• Infectious Disease Surveillance
• +۳ مورد دیگر

Lorin D. Warnick is currently serving as the Austin O. Hooey Dean of Veterinary Medicine at Cornell University College of Veterinary Medicine. He is a tenured Professor in the Department of Population Medicine and Diagnostic Sciences, where his research focuses on the epidemiology of Salmonella infections and antimicrobial resistance in enteric bacteria affecting both domestic animals and humans. A key contributor to Cornell's response to the COVID-19 pandemic, he has led research on SARS-CoV-2 diagnostic testing and campus outbreak dynamics. Education : B.S. in Microbiology (1984) from Brigham Young University DVM (1988) from Colorado State University Ph.D. in Veterinary Medicine (Epidemiology) and Statistics from Cornell University (1994) Professional Experience : Assistant Professor (1994-1996) at Virginia-Maryland Regional College of Veterinary Medicine Assistant/Associate Professor (1996-2008) and Professor (2008-present) at Cornell University Section Chief in Ambulatory and Production Medicine (1997-1999) Research Interests span veterinary epidemiology, antimicrobial resistance, foodborne pathogens, and public health. His work connects animal and human health through One Health frameworks, particularly in Salmonella transmission dynamics between dairy cattle and humans. He has pioneered surveillance systems for infectious diseases, including the model used during Cornell's COVID-19 response. Scientific Awards include: Phi Zeta Veterinary Honor Society (1987) Phi Kappa Phi Honor Society (1988) Honorary Diploma from American Veterinary Epidemiology Society (2018) One Cornell Award for Leadership in Pandemic Testing (2021) Advising and Grants highlight his role in mentoring students and leading interdisciplinary research teams. His grants focus on antimicrobial resistance mitigation, dairy calf health, and pandemic response infrastructure. He has collaborated extensively with institutions like USDA and CDC on foodborne disease research. Labs and Collaborations include leadership in Cornell's Veterinary Diagnostic Laboratories and contributions to the American College of Veterinary Preventive Medicine. His work integrates epidemiological modeling, microbiome analysis, and policy development for sustainable agricultural practices.